Prof Jamie Coleman to give Inaugural Lecture on 7 February 2018

11th January 2018

Professor Jamie Coleman, one of the Principal Investigators of SCRIPT at the University of Birmingham, will be giving his inaugural lecture, with the title “Rewriting the SCRIPT: Educating and Supporting Tomorrow’s Prescribers”. The 1-hour lecture will tell the story (to date) of his influence on the education of prescribers and the implementation of electronic prescribing.

Jamie is a Professor in Clinical Pharmacology and Medical Education at the university, as well as Deputy Programme Director of the MBChB degree course. On his headstone, Jamie would like his epitaph to read “He taught generations of students and doctors to prescribe safely and effectively to benefit patient care”.

The lecture will take place at 4.30pm on Wednesday, 7 February 2018. The venue will be the Leonard Deacon Lecture Theatre in the University of Birmingham’s Medical School. Attendance is free and university staff, students, and the public are all welcome.

View Professor Jamie Coleman’s profile on the University of Birmingham website.

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....